CINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical…
CINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
– Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors;…
– Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors;…
MINNEAPOLIS, April 12, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company…
MINNEAPOLIS, April 12, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company…
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
New program will increase access to affordable genetic testing while also helping to identify and…
New program will increase access to affordable genetic testing while also helping to identify and…
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion system First…
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion system First…
UTRECHT, The Netherlands, April 12, 2023 (GLOBE NEWSWIRE) — ViCentra B.V., the company behind Kaleido,…
UTRECHT, The Netherlands, April 12, 2023 (GLOBE NEWSWIRE) — ViCentra B.V., the company behind Kaleido,…
LONDON, April 12, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…